PCF-Pfizer Health Equity Challenge Awards – Requests for Proposals

Well-being, Health and Biomedical Discovery

Deadlines

Academic Unit: Inquire with your unit

Memorial Deadline: No RGCS Review required for the Request for Proposals - LOI

External Deadline: Friday 9th, April 2021


Description

The Prostate Cancer Foundation (PCF) is the world’s leading philanthropic organization dedicated to funding life-saving prostate cancer research. Founded in 1993, PCF has raised over $865 million to support cutting-edge research by 2,300 scientists at over 244 leading cancer centers in 22 countries around the world. Every FDA-approved life-extending treatment for prostate cancer was seeded and supported by PCF. The overall scientific goal of PCF is to cure prostate cancer. Learn more at pcf.org.

Pfizer Global Medical Grants (GMG) supports the global healthcare community’s independent initiatives (e.g., research, quality improvement or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies. Pfizer’s GMG competitive grant program involves a publicly posted RFP that provides detail regarding a specific area of interest, sets timelines for review and approval, and works with a partner organization or an external review panel to make final grant decisions. Organizations are invited to submit an application addressing the specific gaps in research, practice or care as outlined in the specific RFP. For all Investigator Sponsored Research (ISRs) and general research grants, the grant requester (and ultimately the grantee) is responsible for the design, implementation, sponsorship, and conduct of the independent initiative supported by the grant, including compliance with any regulatory requirements. Pfizer must not be involved in any aspect of study protocol or project development, nor the conduct or monitoring of the research program.

Additional information can be found here.


Funding Sources

Pfizer Inc



This opportunity was posted by: RGCS

Last modified: February 10, 2021